Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, minimize toxicity in Huntington’s disease types and greatly enhance killing of mycobacteria by macrophages. Autophagy Although the new generation of mTOR inhibitors hold excellent promise for anticancer therapy and so are fast moving into clinical trials, there are various critical problems https://solangew752mrv5.blogmazing.com/profile